Dupilumab (anti-IL-4Rα) | Interleukins | Read Reviews & Product Use Citations

Dupilumab (anti-IL-4Rα) is a fully human anti–interleukin-4 receptor α monoclonal antibody that inhibits both interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling through blockade of the shared IL-4α subunit.

Click to purchase the isotype control of Dupilumab (anti-IL-4Rα)

Purity & Quality Control

Batch: Purity: 99.32% Protein concentration: 5.72 mg/ml Endotoxin Level: <1 EU/mg

99.32

Choose Selective Interleukins Inhibitors

Biological Activity

Description	Dupilumab (anti-IL-4Rα) is a fully human anti–interleukin-4 receptor α monoclonal antibody that inhibits both interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling through blockade of the shared IL-4α subunit.

References
[1] Mario Castro, et al. N Engl J Med . 2018 Jun 28;378(26):2486-2496. [2] Melinda J Gooderham, et al. J Am Acad Dermatol . 2018 Mar;78(3 Suppl 1):S28-S36.

References

Product Details

CAS No.	1190264-60-8
Molecular Weight	147 KD
Isotype	Human IgG4, κ
Source	CHO cells
Sterility	0.2 μM filtered
Formulation	PBS Buffer, PH 7.4
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field